HUAWEI
24.3.2023 05:15:29 CET | Business Wire | Press release
Huawei recently held the Top 10 Trends of Data Center Facilities conference, themed "Smart DC, Building the Green Future". Fei Zhenfu, President of Huawei Data Center Facility Domain, released a white paper outlining Huawei's insights on data center facility trends that aim to promote sustainable development in the data center industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230323005815/en/
Fei Zhenfu, President of Huawei Data Center Facility Domain, shared Huawei's insights on the top 10 data center facility trends. (Photo: Business Wire)
According to Mr. Fei, as global computing demand continues to grow exponentially in the digital intelligence era, there will be a surge in data center construction. To achieve carbon neutrality, the industry must prioritize energy conservation, carbon emission reduction, and green transformation. This presents both challenges and opportunities. Drawing from its experience and industry insights, Huawei has identified the following 10 trends:
Trend 1: Low Carbon
Data centers will adopt green, low-carbon solutions and utilize clean energy sources like PV, wind, and hydropower to minimize their carbon footprint. By 2027, green power utilization is expected to exceed 50%. Advanced energy conservation solutions and technologies, such as waste heat recovery, will be implemented to improve data center energy efficiency and recovery rates.
Trend 2: Sustainability
New sustainability indicators for data centers will be introduced, including renewable energy utilization, water usage effectiveness (WUE), carbon usage effectiveness (CUE), space usage effectiveness (SUE), grid usage effectiveness (GUE), material recovery rate, and lifetime contaminant emissions, in addition to the existing power usage effectiveness (PUE).
Trend 3: Fast Deployment
Data centers must be rapidly deployed to meet skyrocketing computing demands, with construction periods decreasing from 12 months to six months or less.
Trend 4: High Density
As chip performance and power consumption improve, the demand for high-density data centers will increase. Cloud data centers will become mainstream, and diversified computing collaboration will become the norm. Standard power density per IT rack will increase from 6–8 kW to 12–15 kW by 2027. Power density in supercomputing and intelligent computing centers will reach 30 kW or higher.
Trend 5: Elasticity
Future data centers will be more flexible regarding upgrades, with one generation of facilities supporting power evolution over two to three generations of IT equipment. A standard design will facilitate on-demand deployment and elastic capacity expansion.
Trend 6: Prefabrication
The prefabricated and simple architecture will tackle challenges like long construction periods and complex O&M faced by traditional data centers. In the future, a data center building will house over 1000 racks, and a campus will accommodate over 10,000 racks. The prefabricated design will shorten the construction period for a 1000-rack data center from 12 months to 6 months, enabling rapid delivery and on-demand deployment.
Trend 7: Storage and Backup Integration
Renewable energy and energy storage will be necessary for power-hungry data centers. Energy storage systems (ESSs) deployments in data centers will integrate short-term backup power systems to participate in frequency regulation and peak shaving, enhancing power grid stability. Peak shaving will also improve the grid usage effectiveness (GUE) so that more IT racks can be deployed to increase revenue.
Trend 8: Distributed Cooling
A distributed cooling system uses cooling sources for each data hall and adopts a redundancy configuration as required. In the future, distributed cooling systems will gradually replace centralized cooling as the preferred solution for large data centers due to their flexible architecture and high reliability.
Trend 9: Smart O&M
Smart O&M is crucial for enhancing data center resource utilization and reliability. Intelligent operations will automatically determine data center asset statuses to maximize asset value. Intelligent maintenance will identify faults and optimize energy conservation in real time to improve O&M efficiency, achieving predictive maintenance and optimal energy efficiency.
Trend 10: Security & Trustworthiness
As digitalization and intelligence advance, data centers will strengthen their hardware reliability, software security, system resilience, safety, privacy, and availability. AI technologies will implement predictive maintenance on components, devices, and systems at the hardware level. The hierarchical defense will be provided at the software level. A combination of software and hardware measures will boost data center reliability.
Moving forward, Huawei will strengthen technological innovation to lead industry development and offer more competitive products and solutions to build a solid digital foundation for a greener, low-carbon future for the data center industry.
For more information, please download the White Paper on the Top 10 Trends of Data Center Facilities at https://digitalpower.huawei.com/attachments/index/06be6a70172444d1a84f88b8e0db5c29.pdf
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230323005815/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom